SHLS Shoals Technologies Group | $9.91 +3.8% | 5/22/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Shoals Technologies Group (NASDAQ:SHLS) on 5/22/2026 |
AMRC Ameresco | $31.82 +5.3% | 5/22/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for Guggenheim rating of Ameresco (NYSE:AMRC) on 5/22/2026 |
ETSY Etsy | $62.48 +2.9% | 5/21/2026 | | Initiated Coverage | | Buy | 00.00% | View details for Guggenheim rating of Etsy (NYSE:ETSY) on 5/21/2026 |
FSLR First Solar | $257.85 +3.6% | 5/21/2026 | | Boost Price Target | $269.00 ➝ $279.00 | Buy | 00.00% | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 5/21/2026 |
OCS Oculis | $29.49 -4.9% | 5/20/2026 | | Initiated Coverage | $75.00 | Buy | 00.00% | View details for Guggenheim rating of Oculis (NASDAQ:OCS) on 5/20/2026 |
HD Home Depot | $313.18 -0.2% | 5/20/2026 | | Reiterated Rating | $425.00 | Buy | 00.00% | View details for Guggenheim rating of Home Depot (NYSE:HD) on 5/20/2026 |
TGT Target | $125.62 -0.4% | 5/20/2026 | | Reiterated Rating | $140.00 | Buy | 00.00% | View details for Guggenheim rating of Target (NYSE:TGT) on 5/20/2026 |
W Wayfair | $67.08 +1.1% | 5/20/2026 | | Reiterated Rating | $100.00 | Buy | 00.00% | View details for Guggenheim rating of Wayfair (NYSE:W) on 5/20/2026 |
EQIX Equinix | $1,079.79 +0.1% | 5/20/2026 | | Reiterated Rating | $1,235.00 | Buy | 00.00% | View details for Guggenheim rating of Equinix (NASDAQ:EQIX) on 5/20/2026 |
OCS Oculis | $29.49 -4.9% | 5/20/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Guggenheim rating of Oculis (NASDAQ:OCS) on 5/20/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
STUB STUB | $9.99 +1.5% | 5/19/2026 | | Upgrade | $8.50 ➝ $12.50 | Neutral ➝ Buy | 00.00% | View details for Guggenheim rating of STUB (NYSE:STUB) on 5/19/2026 |
XE X-Energy | $28.32 -2.3% | 5/19/2026 | | Initiated Coverage | $57.00 | Buy | 00.00% | View details for Guggenheim rating of X-Energy (NASDAQ:XE) on 5/19/2026 |
ESTC Elastic | $54.71 +1.6% | 5/19/2026 | | Lower Price Target | $116.00 ➝ $106.00 | Buy | 00.00% | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 5/19/2026 |
XE X-Energy | $28.32 -2.3% | 5/19/2026 | | Initiated Coverage | $57.00 | Buy | 00.00% | View details for Guggenheim rating of X-Energy (NASDAQ:XE) on 5/19/2026 |
TXRH Texas Roadhouse | $177.57 -0.3% | 5/18/2026 | | Reiterated Rating | $210.00 | Buy | 00.00% | View details for Guggenheim rating of Texas Roadhouse (NASDAQ:TXRH) on 5/18/2026 |
YSWY Yesway | $23.37 +0.3% | 5/18/2026 | | Initiated Coverage | $30.00 | Buy | 00.00% | View details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 5/18/2026 |
STUB STUB | $9.99 +1.5% | 5/15/2026 | | Boost Price Target | $7.50 ➝ $8.50 | Neutral | 00.00% | View details for Guggenheim rating of STUB (NYSE:STUB) on 5/15/2026 |
GTN Gray Media | $4.08 -1.3% | 5/15/2026 | | Lower Price Target | $8.00 ➝ $7.00 | Buy | 00.00% | View details for Guggenheim rating of Gray Media (NYSE:GTN) on 5/15/2026 |
ALMS Alumis | $22.02 -0.7% | 5/15/2026 | | Boost Price Target | $32.00 ➝ $34.00 | Buy | 00.00% | View details for Guggenheim rating of Alumis (NASDAQ:ALMS) on 5/15/2026 |
MSGS Madison Square Garden | $353.80 +0.4% | 5/15/2026 | | Boost Price Target | $401.00 ➝ $422.00 | Buy | 00.00% | View details for Guggenheim rating of Madison Square Garden (NYSE:MSGS) on 5/15/2026 |
NFLX Netflix | $88.60 -0.8% | 5/15/2026 | | Reiterated Rating | $120.00 | Buy | 00.00% | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 5/15/2026 |
UNCY Unicycive Therapeutics | $8.08 +5.9% | 5/13/2026 | | Reiterated Rating | $40.00 ➝ $37.00 | Buy | 00.00% | View details for Guggenheim rating of Unicycive Therapeutics (NASDAQ:UNCY) on 5/13/2026 |
BLLN Billiontoone | $85.92 -0.3% | 5/13/2026 | | Boost Price Target | $100.00 ➝ $120.00 | Buy | 00.00% | View details for Guggenheim rating of Billiontoone (NASDAQ:BLLN) on 5/13/2026 |
CRBP Corbus Pharmaceuticals | $11.35 -1.4% | 5/13/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for Guggenheim rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/13/2026 |
DT Dynatrace | $41.33 +5.6% | 5/13/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 5/13/2026 |
MTZ MasTec | $382.24 -1.7% | 5/13/2026 | | Upgrade | $480.00 | Neutral ➝ Buy | 00.00% | View details for Guggenheim rating of MasTec (NYSE:MTZ) on 5/13/2026 |
OLMA Olema Pharmaceuticals | $13.68 -2.7% | 5/13/2026 | | Lower Price Target | $38.00 ➝ $35.00 | Buy | 00.00% | View details for Guggenheim rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 5/13/2026 |
ONON ON | $39.73 +1.4% | 5/13/2026 | | Reiterated Rating | $51.00 | Buy | 00.00% | View details for Guggenheim rating of ON (NYSE:ONON) on 5/13/2026 |
ELVN Enliven Therapeutics | $41.54 -1.7% | 5/12/2026 | | Initiated Coverage | $80.00 | Buy | 00.00% | View details for Guggenheim rating of Enliven Therapeutics (NASDAQ:ELVN) on 5/12/2026 |
DKNG DraftKings | $25.12 -1.1% | 5/11/2026 | | Lower Price Target | $37.00 ➝ $35.00 | Buy | 00.00% | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 5/11/2026 |
JBIO Jade Biosciences | $22.21 -5.3% | 5/11/2026 | | Boost Price Target | $23.00 ➝ $32.00 | Buy | 00.00% | View details for Guggenheim rating of Jade Biosciences (NASDAQ:JBIO) on 5/11/2026 |
CHRS Coherus Oncology | $1.61 +2.5% | 5/11/2026 | | Initiated Coverage | $12.00 | Buy | 00.00% | View details for Guggenheim rating of Coherus Oncology (NASDAQ:CHRS) on 5/11/2026 |
BCAX Bicara Therapeutics | $21.68 +4.0% | 5/11/2026 | | Initiated Coverage | $42.00 | Buy | 00.00% | View details for Guggenheim rating of Bicara Therapeutics (NASDAQ:BCAX) on 5/11/2026 |
CHRS Coherus Oncology | $1.61 +2.5% | 5/11/2026 | | Initiated Coverage | $12.00 | Buy | 00.00% | View details for Guggenheim rating of Coherus Oncology (NASDAQ:CHRS) on 5/11/2026 |
ELVN Enliven Therapeutics | $41.54 -1.7% | 5/11/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Guggenheim rating of Enliven Therapeutics (NASDAQ:ELVN) on 5/11/2026 |
SHAK Shake Shack | $62.74 -0.1% | 5/11/2026 | | Lower Price Target | $120.00 ➝ $100.00 | Buy | 00.00% | View details for Guggenheim rating of Shake Shack (NYSE:SHAK) on 5/11/2026 |
BCAX Bicara Therapeutics | $21.68 +4.0% | 5/10/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Guggenheim rating of Bicara Therapeutics (NASDAQ:BCAX) on 5/10/2026 |
ZVRA Zevra Therapeutics | $10.03 -4.4% | 5/8/2026 | | Boost Price Target | $23.00 ➝ $25.00 | Buy | 00.00% | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 5/8/2026 |
INSM Insmed | $106.24 -3.0% | 5/8/2026 | | Lower Price Target | $230.00 ➝ $226.00 | Buy | 00.00% | View details for Guggenheim rating of Insmed (NASDAQ:INSM) on 5/8/2026 |
WMG Warner Music Group | $34.72 +0.4% | 5/8/2026 | | Boost Price Target | $34.00 ➝ $36.00 | Buy | 00.00% | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 5/8/2026 |
PH: Do THESE 4 things to your bank account now … (Ad) In a few short months, the US government could gain unprecedented powers over personal bank accounts - including the ability to track every transaction or freeze funds.
Martin D. Weiss, PhD, founder of Weiss Ratings, has identified 4 simple steps Americans can take today to help safeguard their savings before any changes take effect. Discover all 4 steps to help protect your bank account now |
FROG JFrog | $73.99 +3.6% | 5/8/2026 | | Boost Price Target | $60.00 ➝ $80.00 | Buy | 00.00% | View details for Guggenheim rating of JFrog (NASDAQ:FROG) on 5/8/2026 |
AKAM Akamai Technologies | $147.23 +0.7% | 5/8/2026 | | Boost Price Target | $133.00 ➝ $181.00 | Buy | 00.00% | View details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 5/8/2026 |
ARGX argenex | $806.46 -1.2% | 5/8/2026 | | Boost Price Target | $1,120.00 ➝ $1,135.00 | Buy | 00.00% | View details for Guggenheim rating of argenex (NASDAQ:ARGX) on 5/8/2026 |
ARHS Arhaus | $6.32 -1.1% | 5/8/2026 | | Lower Price Target | $14.00 ➝ $12.00 | Buy | 00.00% | View details for Guggenheim rating of Arhaus (NASDAQ:ARHS) on 5/8/2026 |
JANX Janux Therapeutics | $14.52 +0.8% | 5/8/2026 | | Lower Price Target | $68.00 ➝ $58.00 | Buy | 00.00% | View details for Guggenheim rating of Janux Therapeutics (NASDAQ:JANX) on 5/8/2026 |
PLNT Planet Fitness | $52.11 +3.2% | 5/8/2026 | | Lower Price Target | $126.00 ➝ $95.00 | Buy | 00.00% | View details for Guggenheim rating of Planet Fitness (NYSE:PLNT) on 5/8/2026 |
RARE Ultragenyx Pharmaceutical | $23.39 -1.3% | 5/8/2026 | | Lower Price Target | $52.00 ➝ $43.00 | Buy | 00.00% | View details for Guggenheim rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 5/8/2026 |
TTD Trade Desk | $22.38 +5.2% | 5/8/2026 | | Lower Price Target | $28.00 ➝ $25.00 | Buy | 00.00% | View details for Guggenheim rating of Trade Desk (NASDAQ:TTD) on 5/8/2026 |
ENGN enGene | $1.64 -5.2% | 5/7/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of enGene (NASDAQ:ENGN) on 5/7/2026 |
DDOG Datadog | $222.32 +2.0% | 5/7/2026 | | Boost Price Target | $175.00 ➝ $225.00 | Buy | 00.00% | View details for Guggenheim rating of Datadog (NASDAQ:DDOG) on 5/7/2026 |
ONC BeOne Medicines | $310.25 +0.2% | 5/7/2026 | | Boost Price Target | $410.00 ➝ $420.00 | Buy | 00.00% | View details for Guggenheim rating of BeOne Medicines (NASDAQ:ONC) on 5/7/2026 |
RVMD Revolution Medicines | $151.56 -1.4% | 5/7/2026 | | Boost Price Target | $205.00 | Buy | 00.00% | View details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 5/7/2026 |
PTLO Portillo's | $4.03 -1.7% | 5/7/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Portillo’s (NASDAQ:PTLO) on 5/7/2026 |
ARM ARM | $306.51 +2.8% | 5/7/2026 | | Boost Price Target | $240.00 ➝ $255.00 | Buy | 00.00% | View details for Guggenheim rating of ARM (NASDAQ:ARM) on 5/7/2026 |
DIS Walt Disney | $103.12 -0.4% | 5/7/2026 | | Boost Price Target | $115.00 ➝ $120.00 | Buy | 00.00% | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 5/7/2026 |
NYT New York Times | $74.93 +0.9% | 5/7/2026 | | Boost Price Target | $63.00 ➝ $70.00 | Neutral | 00.00% | View details for Guggenheim rating of New York Times (NYSE:NYT) on 5/7/2026 |
WBD Warner Bros. Discovery | $27.03 -0.3% | 5/7/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Warner Bros. Discovery (NASDAQ:WBD) on 5/7/2026 |
SPHR Sphere Entertainment | $129.16 -0.8% | 5/6/2026 | | Boost Price Target | $160.00 ➝ $175.00 | Buy | 00.00% | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 5/6/2026 |
LYV Live Nation Entertainment | $165.74 -0.1% | 5/6/2026 | | Boost Price Target | $192.00 ➝ $197.00 | Buy | 00.00% | View details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 5/6/2026 |
ADPT Adaptive Biotechnologies | $13.88 +0.1% | 5/6/2026 | | Reiterated Rating | $21.00 | Buy | 00.00% | View details for Guggenheim rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 5/6/2026 |
NBIX Neurocrine Biosciences | $156.70 +0.8% | 5/6/2026 | | Reiterated Rating | $175.00 | Buy | 00.00% | View details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/6/2026 |
TWST Twist Bioscience | $60.57 +3.0% | 5/5/2026 | | Boost Price Target | $55.00 ➝ $60.00 | Buy | 00.00% | View details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 5/5/2026 |
CYRX CryoPort | $14.00 -1.5% | 5/5/2026 | | Boost Price Target | $11.00 ➝ $12.00 | Buy | 00.00% | View details for Guggenheim rating of CryoPort (NASDAQ:CYRX) on 5/5/2026 |
ACRS Aclaris Therapeutics | $4.52 -0.4% | 5/5/2026 | | Initiated Coverage | $12.00 | Buy | 00.00% | View details for Guggenheim rating of Aclaris Therapeutics (NASDAQ:ACRS) on 5/5/2026 |
LLY Eli Lilly and Company | $1,066.59 +2.4% | 5/5/2026 | | Reiterated Rating | $1,183.00 | Buy | 00.00% | View details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 5/5/2026 |
PINS Pinterest | $19.25 +2.1% | 5/5/2026 | | Boost Price Target | $21.00 ➝ $24.00 | Buy | 00.00% | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 5/5/2026 |
PSKY Paramount Skydance | $10.46 +1.8% | 5/5/2026 | | Lower Price Target | $14.00 ➝ $12.00 | Neutral | 00.00% | View details for Guggenheim rating of Paramount Skydance (NASDAQ:PSKY) on 5/5/2026 |
SBGI Sinclair | $13.86 +1.8% | 5/5/2026 | | Lower Price Target | $20.00 ➝ $19.00 | Buy | 00.00% | View details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 5/5/2026 |
WGS GeneDx | $47.31 0.0% | 5/5/2026 | | Lower Price Target | $100.00 ➝ $70.00 | Buy | 00.00% | View details for Guggenheim rating of GeneDx (NASDAQ:WGS) on 5/5/2026 |
AXSM Axsome Therapeutics | $235.97 +1.0% | 5/4/2026 | | Boost Price Target | $245.00 ➝ $260.00 | Buy | 00.00% | View details for Guggenheim rating of Axsome Therapeutics (NASDAQ:AXSM) on 5/4/2026 |
ACHC Acadia Healthcare | $23.18 +0.7% | 5/4/2026 | | Boost Price Target | $26.00 ➝ $31.00 | Buy | 00.00% | View details for Guggenheim rating of Acadia Healthcare (NASDAQ:ACHC) on 5/4/2026 |
CELC Celcuity | $138.23 -3.0% | 5/4/2026 | | Boost Price Target | $135.00 ➝ $165.00 | Buy | 00.00% | View details for Guggenheim rating of Celcuity (NASDAQ:CELC) on 5/4/2026 |
ACRS Aclaris Therapeutics | $4.52 -0.4% | 5/4/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Guggenheim rating of Aclaris Therapeutics (NASDAQ:ACRS) on 5/4/2026 |
AMGN Amgen | $339.30 +0.6% | 5/4/2026 | | Lower Price Target | $351.00 ➝ $340.00 | Neutral | 00.00% | View details for Guggenheim rating of Amgen (NASDAQ:AMGN) on 5/4/2026 |
CI Cigna Group | $286.06 +1.4% | 5/4/2026 | | Boost Price Target | $334.00 ➝ $338.00 | Buy | 00.00% | View details for Guggenheim rating of Cigna Group (NYSE:CI) on 5/4/2026 |
DBVT DBV Technologies | $18.18 -2.1% | 5/4/2026 | | Reiterated Rating | $51.00 | Buy | 00.00% | View details for Guggenheim rating of DBV Technologies (NASDAQ:DBVT) on 5/4/2026 |
EPAM EPAM Systems | $102.75 -0.4% | 5/4/2026 | | Lower Price Target | $225.00 ➝ $200.00 | Buy | 00.00% | View details for Guggenheim rating of EPAM Systems (NYSE:EPAM) on 5/4/2026 |
WING Wingstop | $140.41 +5.8% | 5/4/2026 | | Lower Price Target | $255.00 ➝ $215.00 | Buy | 00.00% | View details for Guggenheim rating of Wingstop (NASDAQ:WING) on 5/4/2026 |
ROKU Roku | $125.55 +0.4% | 5/1/2026 | | Boost Price Target | $130.00 ➝ $140.00 | Buy | 00.00% | View details for Guggenheim rating of Roku (NASDAQ:ROKU) on 5/1/2026 |
FND Floor & Decor | $48.09 -0.7% | 5/1/2026 | | Lower Price Target | $90.00 ➝ $65.00 | Buy | 00.00% | View details for Guggenheim rating of Floor & Decor (NYSE:FND) on 5/1/2026 |
ABBV AbbVie | $216.02 +0.7% | 5/1/2026 | | Reiterated Rating | $249.00 | Buy | 00.00% | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 5/1/2026 |
CMG Chipotle Mexican Grill | $32.84 +0.1% | 5/1/2026 | | Lower Price Target | $36.00 ➝ $35.00 | Neutral | 00.00% | View details for Guggenheim rating of Chipotle Mexican Grill (NYSE:CMG) on 5/1/2026 |
REGN Regeneron Pharmaceuticals | $638.88 -0.6% | 5/1/2026 | | Boost Price Target | $975.00 ➝ $995.00 | Buy | 00.00% | View details for Guggenheim rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 5/1/2026 |
THC Tenet Healthcare | $174.00 -2.3% | 5/1/2026 | | Lower Price Target | $283.00 ➝ $252.00 | Buy | 00.00% | View details for Guggenheim rating of Tenet Healthcare (NYSE:THC) on 5/1/2026 |
W Wayfair | $67.08 +1.1% | 5/1/2026 | | Lower Price Target | $120.00 ➝ $100.00 | Buy | 00.00% | View details for Guggenheim rating of Wayfair (NYSE:W) on 5/1/2026 |
BIIB Biogen | $193.76 +2.3% | 4/30/2026 | | Boost Price Target | $246.00 ➝ $260.00 | Buy | 00.00% | View details for Guggenheim rating of Biogen (NASDAQ:BIIB) on 4/30/2026 |
HUM Humana | $307.79 +1.4% | 4/30/2026 | | Boost Price Target | $252.00 ➝ $269.00 | Buy | 00.00% | View details for Guggenheim rating of Humana (NYSE:HUM) on 4/30/2026 |
ETSY Etsy | $62.48 +2.9% | 4/30/2026 | | Boost Price Target | $75.00 ➝ $85.00 | Buy | 00.00% | View details for Guggenheim rating of Etsy (NYSE:ETSY) on 4/30/2026 |
GOOGL Alphabet | $382.97 -1.2% | 4/30/2026 | | Reiterated Rating | $375.00 ➝ $450.00 | Buy | 00.00% | View details for Guggenheim rating of Alphabet (NASDAQ:GOOGL) on 4/30/2026 |
META Meta Platforms | $610.26 +0.5% | 4/30/2026 | | Lower Price Target | $850.00 ➝ $800.00 | Buy | 00.00% | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 4/30/2026 |
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself |
AMZN Amazon.com | $266.32 -0.8% | 4/30/2026 | | Reiterated Rating | $300.00 ➝ $320.00 | Buy | 00.00% | View details for Guggenheim rating of Amazon.com (NASDAQ:AMZN) on 4/30/2026 |
CTSH Cognizant Technology Solutions | $52.75 +0.8% | 4/30/2026 | | Lower Price Target | $85.00 ➝ $80.00 | Buy | 00.00% | View details for Guggenheim rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 4/30/2026 |
ECG Everus Construction Group | $148.06 -1.8% | 4/30/2026 | | Upgrade | $160.00 | Neutral ➝ Buy | 00.00% | View details for Guggenheim rating of Everus Construction Group (NYSE:ECG) on 4/30/2026 |
MSFT Microsoft | $418.57 -0.1% | 4/30/2026 | | Reiterated Rating | $586.00 | Buy | 00.00% | View details for Guggenheim rating of Microsoft (NASDAQ:MSFT) on 4/30/2026 |
UHS Universal Health Services | $157.61 -3.0% | 4/29/2026 | | Lower Price Target | $238.00 ➝ $211.00 | Buy | 00.00% | View details for Guggenheim rating of Universal Health Services (NYSE:UHS) on 4/29/2026 |
SBUX Starbucks | $103.11 -1.0% | 4/29/2026 | | Reiterated Rating | $95.00 ➝ $97.00 | Neutral | 00.00% | View details for Guggenheim rating of Starbucks (NASDAQ:SBUX) on 4/29/2026 |
CRBP Corbus Pharmaceuticals | $11.35 -1.4% | 4/29/2026 | | Initiated Coverage | $45.00 | Buy | 00.00% | View details for Guggenheim rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 4/29/2026 |
CRBP Corbus Pharmaceuticals | $11.35 -1.4% | 4/29/2026 | | Initiated Coverage | $45.00 | Buy | 00.00% | View details for Guggenheim rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 4/29/2026 |
SGMT Sagimet Biosciences | $7.09 +1.3% | 4/29/2026 | | Lower Price Target | $27.00 ➝ $25.00 | Buy | 00.00% | View details for Guggenheim rating of Sagimet Biosciences (NASDAQ:SGMT) on 4/29/2026 |
SPOT Spotify Technology | $518.92 +5.9% | 4/29/2026 | | Lower Price Target | $600.00 ➝ $565.00 | Buy | 00.00% | View details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 4/29/2026 |